J.H.M. Driessen

van Oostwaard, M. M., Bevers, M. S. A. M., Driessen, J. H. M., de Jong, M., Heijnen, M. L. G. J., Wyers, C. E., & van den Bergh, J. P. (2025). Bone microarchitecture and strength in men with prostate cancer with and without prevalent vertebral fractures at the initiation of androgen deprivation therapy. Bone, 201, Article 117643. https://doi.org/10.1016/j.bone.2025.117643

Werkman, N. C. C., Nielen, J. T. H., Tapia-Galisteo, J., Somolinos-Simon, F. J., Hernando, M. E., Wang, J., Jiu, L., Goettsch, W. G., Bosma, H., Schram, M. T., van Greevenbroek, M. M. J., Wesselius, A., Stehouwer, C. D. A., Driessen, J. H. M., & Garcia-Saez, G. (2025). Prediction of glycaemic control and quality of life in people with type 2 diabetes using glucose-lowering drugs with machine learning-The Maastricht study. Diabetes Obesity & Metabolism, 27(10), 5524-5537. https://doi.org/10.1111/dom.16598

Keene, S. J., Driessen, J. H. M., Jordan, R. E., Sitch, A., Adab, P., & Franssen, F. M. E. (2025). The independent and combined effects of smoking and chronic obstructive pulmonary disease on body mass index trajectories. Scientific Reports, 15(1), Article 32883. https://doi.org/10.1038/s41598-025-17270-0

van Hulten, V., Souverein, P. C., Starup-Linde, J., Viggers, R., Klungel, O. H., Vestergaard, P., Brouwers, M. C. J. G., van den Bergh, J. P., & Driessen, J. H. M. (2024). The association of type 2 diabetes-related characteristics with fracture risk at different sites. Diabetes Obesity & Metabolism, 26(11), 4887-4896. https://doi.org/10.1111/dom.15884

van Oostwaard, M. M., Wyers, C. E., Driessen, J. H. M., van Maren, M., de Jong, M., van de Wouw, A. J., Janssen-Heijnen, M. L. G., & van den Bergh, J. P. (2024). The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy. Osteoporosis International, 35(11), 2037-2045. https://doi.org/10.1007/s00198-024-07180-8

Van Hulten, V., Driessen, J. H. M., Andersen, S., Kvist, A., Viggers, R., Bliuc, D., Center, J. R., Brouwers, M. C. J. G., Vestergaard, P., & van den Bergh, J. P. (2024). Fracture risk revisited: Bone mineral density T-score and fracture risk in type 2 diabetes. Diabetes Obesity & Metabolism, 26(11), 5325-5335. https://doi.org/10.1111/dom.15890

Van Hulten, V., Sarodnik, C., Driessen, J. H. M., Viggers, R., Rasmussen, N. H., Geusens, P. P. M. M., Schaper, N., Schram, M. T., De Galan, B. E., Koster, A., Bours, S. P. G., Vestergaard, P., Stehouwer, C. D. A., & van den Bergh, J. P. (2024). Bone microarchitecture and strength assessed by HRpQCT in individuals with type 2 diabetes and prediabetes: the Maastricht study. JBMR plus, 8(9), Article ziae086. https://doi.org/10.1093/jbmrpl/ziae086

Werkman, N. C. C., Driessen, J. H. M., Klungel, O. H., Schaper, N. S., Souverein, P. C., Stehouwer, C. D. A., & Nielen, J. T. H. (2024). Incretin-based therapy and the risk of diabetic foot ulcers and related events. Diabetes Obesity & Metabolism, 26(9), 3764-3780. https://doi.org/10.1111/dom.15721

Schene, M. R., Willems, H. C., Driessen, J. H. M., Vranken, L., Heersprink, F. O. L., Janzing, H. M. J., van der Velde, R. Y., van den Bergh, J. P., & Wyers, C. E. (2024). Physical performance and sarcopenia assessment in patients with a recent fracture visiting the Fracture Liaison Service. Osteoporosis International, 35(5), 851-862. https://doi.org/10.1007/s00198-023-07009-w

Gulikers, J. L., Veerman, G. D. M., Jebbink, M., Kruithof, P. D., Steendam, C. M. J., Boosman, R. J., Mathijssen, R. H. J., Tjan-Heijnen, V. C. G., Driessen, J. H. M., Dursun, S., Smit, E. F., Dingemans, A. M. C., van Geel, R. M. J. M., Croes, S., & Hendriks, L. E. L. (2024). Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC. JTO Clinical and Research Reports, 5(4), Article 100656. https://doi.org/10.1016/j.jtocrr.2024.100656